0 CHECKOUT

Pakistan Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3456711
  • November 2015
  • Region: Pakistan
  • 106 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Ferozsons Laboratories
  • Getz Pharma
  • GlaxoSmithKline (GSK)
  • Hilton Pharma
  • Novartis
  • MORE

Healthcare access will remain limited by Pakistan's fragmented medical system. Effective improvements to this will require a consolidation of healthcare policy, as the devolution of responsibilities to provincial authorities have created uneven healthcare access while Pakistan's mixed medical delivery model sees overlapping services and wastage. However, such a move is unlikely given the lack of policy continuity in the country, thus demanding that pharmaceutical firms scope their strategies at the provincial level while accounting for the highly fragmented delivery of healthcare.

Headline Expenditure Projections
- Pharmaceuticals: PKR231.23bn (USD2.29bn) in 2014 to PRK252.42bn (USD2.46bn) 2015; +9.2%in local currency terms and +7.3% in US dollar terms.

- Healthcare: PKR698.82bn (USD6.92bn) in 2014 to PKR773.22bn (USD7.52n) in 2015; +10.6% in local currency terms and +8.8% in US dollar terms.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Ferozsons Laboratories
  • Getz Pharma
  • GlaxoSmithKline (GSK)
  • Hilton Pharma
  • Novartis
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Pakistan 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Pakistan 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2011-2019)
Table: Government Healt Expenditure Trends, Historical Data And Forecasts (Pakistan 2010-2018)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2011-2019)

Prescription Drug Market Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Pakistan 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Pakistan 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Pakistan 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Pakistan 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Pakistan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Pakistan 2013-2019)

Industry Risk Reward Index

Asia Pacific Risk/Reward Index

Pakistan Risk/Reward Index

Rewards

Risks

Regulatory Review

Regulatory Developments

Intellectual Property Issues

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (Pakistan 2009-2014)
Table: Healthcare Personnel (Pakistan 2009-2014)
Table: Healthcare Activity (Pakistan 2009-2014)

Research & Development

Clinical Trials

Epidemiology
Table: Diabetic Patients' Education Level & Compliance Levels
Table: Estimated Number Of New Cases Of Cancer In Pakistan
Table: Frequency Of Information Provided To Patients As A Percentage Of Total Cases

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Generic Drugmakers
Table: PPMA As Of 2015

Pharmaceutical Distribution

Company Profile

Abbott Laboratories

Efroze Chemical Industries

Ferozsons Laboratories

Getz Pharma

GlaxoSmithKline (GSK)

Hilton Pharma

Novartis

Pfizer

Sanofi-Aventis

Searle Pakistan Limited

Demographic Forecast
Table: Population Headline Indicators (Pakistan 1990-2025)
Table: Key Population Ratios (Pakistan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Pakistan 1990-2025)
Table: Population By Age Group (Pakistan 1990-2025)
Table: Population By Age Group % (Pakistan 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Abbott Laboratories
Efroze Chemical Industries
Ferozsons Laboratories
Getz Pharma
GlaxoSmithKline (GSK)
Hilton Pharma
Novartis
Pfizer
Sanofi-Aventis
Searle Pakistan Limited

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S